SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy
Clinical trial NCT03417895 · COMPLETED
Trial details
- NCT number
- NCT03417895
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-20
- Primary completion
- 2021-08-04
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.